Novo Nordisk A/S – aktietilbagekøbsprogram
/
Date28 Nov 2016
Bagsværd, 2016-11-28 – Den 28. oktober 2016 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og Rådets forordning (EU) nr. 596/2014... Read More →
First Capital, Inc. Announces Quarterly Dividend
/
Date28 Nov 2016
CORYDON, Ind., Nov. 28, 2016 (GLOBE NEWSWIRE) — The Board of Directors of First Capital, Inc. (NASDAQ:FCAP) has declared a quarterly cash dividend of $0.21... Read More →
Empresas ICA, S.A.B. de C.V.
/
Date28 Nov 2016
MEXICO CITY, Nov. 28, 2016 (GLOBE NEWSWIRE) — Empresas ICA, S.A.B. de C.V. (BMV:ICA), announced today its unaudited results for the third quarter of 2016,... Read More →
BidEnergy Acquires RealWinWin
/
Date28 Nov 2016
Deal Brings New Energy Efficiency Accounting Capabilities to BidEnergy’s Source-to-Pay Automation Platform Platform Helps CFOs Manage Last Spend Category “Hiding in Plain Sight,” Prepare for... Read More →
HB Grandi: Kynning á uppgjöri þriðja ársfjórðungs
/
Date28 Nov 2016
HB Grandi mun birta uppgjör sitt fyrir þriðja ársfjórðung eftir lokun markaða miðvikudaginn 30. nóvember. Opinn kynningarfundur verður haldinn fimmtudaginn 1. desember klukkan 8:30 í... Read More →
Novo Nordisk A/S – Share repurchase programme
/
Date28 Nov 2016
Bagsværd, Denmark, 28 November 2016 – On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No.... Read More →
Global Natural Food Color Market expected to reach USD 1.77 Billion by 2021: Zion Market Research
/
Date28 Nov 2016
Sarasota, FL, Nov. 28, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Natural Food Color Market (Carotenoid, Anthocyanin, Caramel) For Confectionary,... Read More →
Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 and Feedback from the FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors
/
Date28 Nov 2016
Conference Call Today at 4:30 p.m. ET Highlights: Sales for the third quarter of 2016 increased 15.4% compared to the third quarter of 2015 Closed... Read More →
Alder BioPharmaceuticals Initiates PROMISE 2 Pivotal Trial of Eptinezumab for the Prevention of Migraine
/
Date28 Nov 2016
BOTHELL, Wash., Nov. 28, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the initiation of... Read More →
Will Trump Allow Banks to Operate Again Like Hedge Funds?
/
Date28 Nov 2016
The Trump campaign has offered scant details about its promise to “dismantle” the Dodd-Frank Act, leaving many to wonder whether his administration will allow them... Read More →